Search

John S. Kenyon

Examiner (ID: 1783, Phone: (571)270-1567 , Office: P/1625 )

Most Active Art Unit
1625
Art Unit(s)
1625, 1622
Total Applications
1238
Issued Applications
858
Pending Applications
135
Abandoned Applications
275

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18329173 [patent_doc_number] => 11634401 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-25 [patent_title] => Process-scale synthesis of urolithin A [patent_app_type] => utility [patent_app_number] => 17/141472 [patent_app_country] => US [patent_app_date] => 2021-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8041 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17141472 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/141472
Process-scale synthesis of urolithin A Jan 4, 2021 Issued
Array ( [id] => 18287249 [patent_doc_number] => 20230102721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => NOVEL ORGANIC ELECTRON TRANSFER MEDIATOR AND DEVICE COMPRISING SAME [patent_app_type] => utility [patent_app_number] => 17/787389 [patent_app_country] => US [patent_app_date] => 2020-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13238 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17787389 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/787389
Organic electron transfer mediator and device comprising same Dec 27, 2020 Issued
Array ( [id] => 18181796 [patent_doc_number] => 20230042525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => JAK KINASE INHIBITOR PHARMACEUTICAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/786647 [patent_app_country] => US [patent_app_date] => 2020-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4231 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786647 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/786647
JAK KINASE INHIBITOR PHARMACEUTICAL COMPOSITION Dec 21, 2020 Abandoned
Array ( [id] => 17687626 [patent_doc_number] => 20220194918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => PLEUROMULIN LIPOIC ACID ESTER WITH ANTIBACTERIAL ACTIVITY AND A METHOD OF PREPARING THE SAME [patent_app_type] => utility [patent_app_number] => 17/128103 [patent_app_country] => US [patent_app_date] => 2020-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3848 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17128103 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/128103
Pleuromulin lipoic acid ester with antibacterial activity and a method of preparing the same Dec 18, 2020 Issued
Array ( [id] => 18158337 [patent_doc_number] => 20230024928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-26 [patent_title] => CAI NANOEMULSIONS [patent_app_type] => utility [patent_app_number] => 17/785842 [patent_app_country] => US [patent_app_date] => 2020-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10604 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17785842 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/785842
CAI nanoemulsions Dec 17, 2020 Issued
Array ( [id] => 18817403 [patent_doc_number] => 20230391743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-07 [patent_title] => METHOD OF PREPARING ORGANOSULFUR COMPOUND [patent_app_type] => utility [patent_app_number] => 18/034025 [patent_app_country] => US [patent_app_date] => 2020-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9288 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 214 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18034025 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/034025
Method of preparing organosulfur compound Dec 17, 2020 Issued
Array ( [id] => 16946597 [patent_doc_number] => 20210205288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ATTENTION DEFICIT DISORDER AND 22Q SYNDROME [patent_app_type] => utility [patent_app_number] => 17/125164 [patent_app_country] => US [patent_app_date] => 2020-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21116 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17125164 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/125164
Nonselective metabotropic glutamate receptor activators for treatment of attention deficit disorder and 22Q syndrome Dec 16, 2020 Issued
Array ( [id] => 16777922 [patent_doc_number] => 20210114999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => TARGETING STAT SUMOYLATION TO ENHANCE IMMUNE RESPONSES [patent_app_type] => utility [patent_app_number] => 17/125900 [patent_app_country] => US [patent_app_date] => 2020-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21685 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17125900 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/125900
Targeting STAT sumoylation to enhance immune responses Dec 16, 2020 Issued
Array ( [id] => 18280613 [patent_doc_number] => 20230096085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => FLUORINE-CONTAINING PYRIMIDINE COMPOUND AND PRODUCTION METHOD THEREFOR [patent_app_type] => utility [patent_app_number] => 17/795670 [patent_app_country] => US [patent_app_date] => 2020-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6327 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795670 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/795670
FLUORINE-CONTAINING PYRIMIDINE COMPOUND AND PRODUCTION METHOD THEREFOR Dec 15, 2020 Pending
Array ( [id] => 18283949 [patent_doc_number] => 20230099421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => A NEW METHOD OF 18F LABELLING AND INTERMEDIATE SALTS [patent_app_type] => utility [patent_app_number] => 17/757653 [patent_app_country] => US [patent_app_date] => 2020-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19482 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17757653 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/757653
A NEW METHOD OF 18F LABELLING AND INTERMEDIATE SALTS Dec 14, 2020 Pending
Array ( [id] => 18181059 [patent_doc_number] => 20230041788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => OPHTHALMIC COMPOSITIONS COMPRISING D2O [patent_app_type] => utility [patent_app_number] => 17/784841 [patent_app_country] => US [patent_app_date] => 2020-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69346 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -97 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17784841 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/784841
OPHTHALMIC COMPOSITIONS COMPRISING D2O Dec 14, 2020 Pending
Array ( [id] => 18964143 [patent_doc_number] => 11897893 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-13 [patent_title] => Molecular containers and methods of making and using same [patent_app_type] => utility [patent_app_number] => 17/121241 [patent_app_country] => US [patent_app_date] => 2020-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 51 [patent_no_of_words] => 14277 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17121241 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/121241
Molecular containers and methods of making and using same Dec 13, 2020 Issued
Array ( [id] => 18306478 [patent_doc_number] => 20230110378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => MONOBACTAM COMPOUND AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/784971 [patent_app_country] => US [patent_app_date] => 2020-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41273 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 589 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17784971 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/784971
MONOBACTAM COMPOUND AND USE THEREOF Dec 10, 2020 Abandoned
Array ( [id] => 18194010 [patent_doc_number] => 20230047529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-16 [patent_title] => METHOD FOR SYNTHESIZING ZIRCONIUM COMPLEX [patent_app_type] => utility [patent_app_number] => 17/784368 [patent_app_country] => US [patent_app_date] => 2020-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9333 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 553 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17784368 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/784368
Method for synthesizing zirconium complex Dec 7, 2020 Issued
Array ( [id] => 16777917 [patent_doc_number] => 20210114994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => Methods for the synthesis of activated ethylfumarates and their use as intermediates [patent_app_type] => utility [patent_app_number] => 17/113540 [patent_app_country] => US [patent_app_date] => 2020-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11359 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17113540 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/113540
Methods for the synthesis of activated ethylfumarates and their use as intermediates Dec 6, 2020 Issued
Array ( [id] => 17412018 [patent_doc_number] => 20220046922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => LIQUID PESTICIDAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/109400 [patent_app_country] => US [patent_app_date] => 2020-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19142 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17109400 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/109400
LIQUID PESTICIDAL COMPOSITION Dec 1, 2020 Abandoned
Array ( [id] => 18109454 [patent_doc_number] => 20230002334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => TRPM8 MODULATORS [patent_app_type] => utility [patent_app_number] => 17/777910 [patent_app_country] => US [patent_app_date] => 2020-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45985 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17777910 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/777910
TRPM8 MODULATORS Nov 25, 2020 Pending
Array ( [id] => 18359607 [patent_doc_number] => 20230141198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => PYRAZOLOMORPHINAN DERIVATIVE [patent_app_type] => utility [patent_app_number] => 17/777536 [patent_app_country] => US [patent_app_date] => 2020-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22323 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17777536 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/777536
PYRAZOLOMORPHINAN DERIVATIVE Nov 19, 2020 Abandoned
Array ( [id] => 18180913 [patent_doc_number] => 20230041642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => Aggregation Inhibitory Agent and Medical Composition and Medical Device Including Same [patent_app_type] => utility [patent_app_number] => 17/785612 [patent_app_country] => US [patent_app_date] => 2020-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17441 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17785612 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/785612
Aggregation Inhibitory Agent and Medical Composition and Medical Device Including Same Nov 18, 2020 Abandoned
Array ( [id] => 18336739 [patent_doc_number] => 20230128688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => DIRECTED CONJUGATION TECHNOLOGIES [patent_app_type] => utility [patent_app_number] => 17/769924 [patent_app_country] => US [patent_app_date] => 2020-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 110752 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769924 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/769924
DIRECTED CONJUGATION TECHNOLOGIES Nov 17, 2020 Pending
Menu